The tariff classification and country of origin marking of LUPRON DEPOT 7.5 mg (leuprolide acetate for depot suspension) prefilled dual-chamber syringe; and the tariff classification of plastic plungers for syringes from Japan
Reasoning
The tariff classification and country of origin marking of LUPRON DEPOT 7.5 mg (leuprolide acetate for depot suspension) prefilled dual-chamber syringe; and the tariff classification of plastic plungers for syringes from Japan
Cite this ruling
CBP Ruling C85112 (3004390050): The tariff classification and country of origin marking of LUPRON DEPOT 7.5 mg (leuprolide acetate for depot suspension) prefilled dual-chamber syringe; and the tariff classification of plastic plungers for syringes from Japan
Paste this into a product's override reason when citing this ruling as justification for a classification.
Other rulings for HS6 300439
The tariff classification of Biomed 101 capsules and Atamestane tablets from Canada
The tariff classification of Finasteride (CAS-98319-26-7), in bulk form, and Proscar® tablets, both imported from various countries
The tariff classification of Lumigan™(bimatoprost ophthalmic solution) 0.03%, put up in plastic, ophthalmic dispenser-bottles
The tariff classification of Blephamide® (sulfacetamide sodium and prednisolone acetate ophthalmic ointment USP) 10% / 0.2%
The tariff classification of Blephamide® (sulfacetamide sodium - prednisolone acetate ophthalmic suspension) 10% / 0.2%